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OutcomeNeurocognitive dysfunction is common in schizophrenia but its course and determinants remain uncertain.
Our aim was to analyse if premorbid school performance and the severity of illness and functioning predict
change in cognition in schizophrenia in a general population sample.
The sample included cases with schizophrenia spectrum disorder from the Northern Finland Birth Cohort
1966. Data on school marks at the age of 16 years, educational level at the age of 34 years, severity of
symptoms and occupational functioning around ﬁrst episode and after years of illness were gained from
national registers, hospital notes and interviews. Change of verbal and visual learning and memory and
executive functioning were examined between ages 34 and 43 years. The number of cases varied in analyses
from 29 to 41, depending on missing data in particular cognitive tests.
Lower school marks at age 16 years and lower education at age 34 years predicted more decline of cognition.
Measures of severity of illness or functioningwere not associated statistically signiﬁcantly with change of cognition.
Premorbid school performance, but not later course of schizophrenia, related to change of cognition inmidlife. Poor
premorbid scholastic performance and post-onset cognitive decline may represent related processes as part of an
endophenotype of schizophrenia.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neurocognitive deﬁcits in schizophrenia are associated with
functional impairments (Ekerholm et al., 2012; Hedman et al., 2013,
Mesholam-Gately et al., 2009, Touloupoulou and Murray, 2004).
Understanding more about the predictors of neurocognitive function
in schizophrenia is of theoretical and potential practical importance.
However, the longitudinal course of cognitive functioning and its
predictors in schizophrenia remain unclear (Bora and Murray, 2014;
Bozikas and Andreou, 2011; Irani et al., 2010). Longitudinally, in one
study, 10-years follow-up duration of untreated psychosis (DUP) andologyandSystemsMedicine, P.O.
8 40 7474376.
läinen).
Inc. This is an open access article uchange of IQ did not relate, but a subgroupwith long duration of active
psychosis after the start of treatment demonstrated a signiﬁcant
cognitive decline (Barder et al., 2014). Low education, instead, has
been associated with decline in selective attention over 4.5 years
follow-up (Ekerholm et al., 2012) and decline in other cognitive
scores (e. g., immediate memory, language, delayed memory) (Han
et al., 2012); these results, combined with prior studies suggesting
that scholastic performance may predict schizophrenia risk (Jones
et al., 1994; MacCabe et al., 2008) and illness severity (Lauronen et al.,
2007; Mäkinen et al., 2010), encouraged us to further investigate
whether premorbid scholastic performance is associated with
subsequent course of cognition in schizophrenia within the popula-
tion based setting of the Northern Finland Birth Cohort 1966. Given
previous evidence that higher amount of relapses associated with poorer
cognitionmeasured repeatedly at 5-years follow-up (Barder et al., 2013),nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cognitive decline.
Here, our aim was to analyse premorbid school performance,
educational level and severity of illness and occupational functioning
as predictors of cognitive change in schizophrenia. We hypothesized
that both poor school performance and lower educational level, and
more severe illness during the ﬁrst episode and later course of illness,
would associate with more decline in cognition.
2. Methods
2.1. Participants
The Northern Finland Birth Cohort 1966 (NFBC 1966) is an unselected
general population birth cohort ascertained during mid-pregnancy,
consisting 12,058 live-born children in the provinces of Lapland and
Oulu with an expected delivery date during 1966. There were 11,017
eligible individuals in Finland at the age of 16 years. Of them, 83
individuals did not consent to the use of their data and have been
excluded. The Ethical Committee of the Northern Ostrobothnia Hospital
District has approved the study design of the NFBC 1966. The current
study has been performed in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki and its later amendments.
A baseline study of this sample was conducted in 1999–2001
(around the age of 34 years), with follow-up in 2008–2010 (around
the age of 43 years). Participants were given a complete description
of the study and had an opportunity to refuse to participate. All
participants provided written informed consent (Husa et al., 2014,
Kobayashi et al., 2014, Rannikko et al., 2015, Veijola et al., 2014).
2.2. Case identiﬁcation
All cohort members over 16 years appearing on the nationwide
Finnish Hospital Discharge Register (FHDR) until the end of 1997 for
any mental disorder (i.e. ICD-8 diagnoses 290–309, ICD-9 290–316,
and ICD-10 F00–F69, F99) were identiﬁed. All case records were
scrutinized and diagnoses were validated for the DSM-III-R criteria.
The reliability of researchers assessing schizophrenia diagnoses was
good (kappa = 0.85) (Moilanen et al., 2003).
2.2.1. Baseline study
During 1999–2001 around the age of 34 years all 146 living cases
with diagnosis of psychosis (62 females, 42%) were invited to
participate in the baseline study. Altogether 92 (63%) cases (72
(79%) with schizophrenia spectrum disorders) participated. The
Structured Clinical Interview for DSM-III-R (SCID I; Spitzer et al.,
1989) was used for diagnostic assessment, together with all available
information on illness history including individual medical records.
The examination also included cognitive tests described below. After
diagnostic interviews a total of 61 cases with a lifetime diagnosis of
schizophrenia and 12 cases with other schizophrenia spectrum
disorder were detected. Mean duration of illness of all these cases was
10.2 years (standard deviation, SD 4.3) at the baseline. The baseline
study in 1999–2001 is presented in detail in Haapea et al. (2007).
2.2.2. Follow-up study
The follow-up study took place in 2008–2010 when the partici-
pants were around age 43 years. All the participants of the baseline
study were invited to participate in the follow-up, and 44 (61%)
individuals with schizophrenia spectrum disorder participated. The
follow-up study included diagnostic interview (SCID-I, First et al.,
2002) and the same cognitive tests as done at baseline. The original
diagnoses were validated at follow-up for all subjects based on the
SCID interview and by review of medical records. The mean durationof illness until the follow-up study was 20.0 (SD 4.1) (Husa et al.,
2014, Kobayashi et al., 2014, Rannikko et al., 2015, Veijola et al., 2014).
2.2.3. Final sample
The present study is based on those 41 individuals with a
schizophrenia spectrum disorder for whom data on cognition was
available at both baseline and follow-up. The schizophrenia spectrum
group included the following DSM-III-R diagnoses: schizophrenia
295.1 (n = 9); 295.3 (n = 8); 295.6 (n = 1); 295.9 (n = 16);
schizophreniform psychosis 295.4 (n = 1), schizoaffective disorder
295.7 (n = 5) and delusional disorder 297.1 (n = 1). Hereafter in
this paper the term “schizophrenia” is used for schizophrenia and
other schizophrenia spectrum disorders. The mean follow-up time
between baseline and follow-up study was 9.1 years (SD 0.6) years.
2.3. Analysis of attrition
The ﬁnal sample (n = 41) did not differ from those who
participated in the baseline study but not the follow-up in gender,
in a summary measure of the CVLT (correct responses in trials 1–5) at
baseline, in PANSS total symptoms, onset age or number of psychiatric
hospital treatment days. Compared to non-participants, participants
had statistically signiﬁcantly lower educational level at age of 31 years
(based on national register data) (p = 0.038). The only ﬁve cases
with tertiary education did not participate in the follow-up study.
The ﬁnal sample (n = 41) did not differ from all the other
schizophrenia spectrum cases of the whole NFBC 1966 regarding
educational level at the age of 31 years, being or not being on disability
pension, or cumulative number of psychiatric hospital treatment days.
2.4. Outcomes – neuropsychological assessments and change of cognition
A neuropsychological battery included the CVLT (California Verbal
Learning Test; Delis et al., 1987), the VOLT (Visual Object Learning
Test; Glahn et al., 1997) and the AIM (Abstraction, Inhibition,
Memory; Glahn et al., 2000). These tests were administered at both
baseline and follow-up (Juola et al., under revision, Kobayashi et al.,
2014, Rannikko et al., 2015).
2.4.1. Verbal learning and memory
The CVLT was administered and scored by trained examiners in a
ﬁxed order in exactly the same way at baseline and follow-up. The
CVLT was the only word-list memory task administered in a given
neuropsychological test session to minimize possible interference
effects between tests. The CVLT provides a brief, individually adminis-
tered assessment of multiple strategies, processes, and errors involved
in learning and remembering verbal material (Delis et al., 1987).
The followingvariables describingdifferent domains of verbal learning
and memory were analysed in this study: 1. Immediate free recall –
performance (correct responses) on List A provides a sum of trials 1
through 5. 2. Long delay free recall – the number of correct responses on
List A in any order and by category after 15–20 min interval, reﬂects the
examinee´s ability to retain verbal informationover time. 3.All intrusions–
the type of recall errors,which are responses not on the target list on short
and long delay.
2.4.2. Visual learning and memory
The VOLT, a measure of visual-spatial learning and memory, was
developed to examine aspects of visual-spatial learning and memory
in a manner analogous to available verbal tests (e.g., CVLT). Like the
CVLT, the VOLT has multiple learning trials, although the VOLT
consists of four rather than ﬁve, followed by an interference list, as
well as short delay and long delay trials (Glahn et al., 1997).
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The AIM task is a computerized rule-abstraction/category learning
task that requires subjects to use information to group stimuli in a
meaningful way on the basis of feedback received during the test. In
this task, manipulation of information is operationalized as visual
abstraction. This task yields 2 outcome measures: total score on the
abstraction trials and total score on the trials involving abstraction
withmemory (Glahn et al., 2000). Participants who performing below
chance, i.e. who had less than 50% of correct answers were excluded.
2.5. Predictors of change of cognition
2.5.1. School marks at 16 years of age
Information on school marks at the age of 16 years was acquired from
registers of the national application system for secondary education after
compulsory schooling (Isohanni et al., 1998). In Finland, schoolmarks range
from4 to10. Each set ofmarks is deﬁned in the followingway: 4 is rejected,
5–6arepoor, 7–8are satisfactoryand9–10areexcellent. Themeanscoresof
all subjects, and theoretical and practical subjects, separately, were
calculated from the school reports. The theoretical subjects at the time
when the participantswere 16 years of agewere: native language, reading;
native language, literal; second, third, fourth and ﬁfth language; mathe-
matics; chemistry; physics; history; biology; geography; religion and civics.
The practical subjects were: physical education, music, drawing, craft,
domestic science, commercial subjects, typewriting, and agriculture.
2.5.2. Educational level at the age of 34 years
Level of basic education at the age of 34 years (‘O’ level, 9 years; or ‘A’
level, 12 years) and vocational education (none, course or school,
currently studying, college, polytechnic, or university) was ascertained
in the baseline questionnaire. Thesewere combined as level of education:
Basic = O level with low vocational education (none, course or school, or
currently studying); secondary = O level with high vocational education
(college, polytechnic, or university), or A level with low vocational
education; and tertiary = A level with high vocational education.
2.5.3. Measures of severity of illness and occupational functioning
around ﬁrst episode
2.5.3.1. Severity of positive and negative symptoms around ﬁrst episode.
The presence of symptoms at the ﬁrst psychotic episode was assessed
retrospectively from the medical records using the Operational
Criteria Checklist for Psychotic Illness (OPCRIT) (McGufﬁn et al.,
1991). The symptomswere categorized using the factors presented by
Matsuura et al. (2004). The amount of positive (includes items 73, 67,
61, 68, 75, 55, and 66), and negative symptoms (items 24, 29, 32, 33,
and 25) were analysed separately as continuous variables.
2.5.3.2. Occupational functioning around ﬁrst episode. Occupational
functioning was deﬁned as the person achieving his/her premorbid
occupational level, and was split into three categories: 1. unemployed
for all of the time, before and after illness onset 2. employment
decreased or was less than 50% of the time after illness onset 3.
employment did not decrease or accounted for more than 50% of the
time after illness onset. Decreases and increases in employment were
deﬁned by using the proportion of employment two years after the
illness onset divided by the proportion of employment two years before
the illness onset (Penttilä et al., 2013). Data about employment was
received from the nationwide register of the Finnish Centre for Pensions.
2.5.4. Measures of severity of illness and occupational functioning at
later course of illness
Severity of positive and negative symptoms at the age of 34 years
was assessed by the Positive and Negative Syndrome Scale (PANSS)(Kay et al., 1987). At the baseline study positive and negative
dimensions of the PANSS were used to measure the amount of
psychopathological, especially psychotic, symptoms during the
previous week. This variable was analysed as continuous.
2.5.4.1. Occupational status at the age of 34 years. Occupational
capacity was deﬁned as follows: Good occupational capacity = not
on disability pension and working at least 50% of time during the year
2000 (i.e. at aroundage 34-years) vs. poor occupational outcome = working
less than 50% of time and/or on disability pension. The information was
combined using data from the pension register of the Social Insurance
Institution of Finland and from the register of work periods of the
Finnish Center for Pensions.
2.6. Characteristics of the sample
2.6.1. Gender
Male vs. female.
2.6.2. Alcohol use disorder by the baseline
Information on an earlier or current diagnosis of both alcohol
abuse and dependency was ascertained in the SCID I interview
at baseline.
Cumulative number of hospital treatment days of the cases was
derived from the Care Register for Health Care).
Age of illness onset was based on evaluation of medical records
(Penttilä et al., 2010), and used also as confounding variable in all
analyses. Age of illness onset in this sample indicates roughly also
length of illness. Since this being a birth cohort sample, the cases had
varying length of illness, hence adjusting with age of illness onset was
considered important.
Current use of antipsychotic medication was obtained by interview
at baseline study.
2.7. Statistical analyses
Statistical analyses were implemented using IBM SPSS Statistics
(version 22). Characteristics of the data are presented with mean
values, standard deviations (SDs), frequencies and percentages.
Associations between change of cognitive test scores between 34-
and 43-years and the predictors were analysed using linear regression
models. All the analyses were adjusted for corresponding baseline
cognitive score and age of illness onset. P-values b0.05were considered
as statistically signiﬁcant.
3. Results
3.1. Characteristics of the sample
The mean age of illness onset in cases was 23.6 years (SD 4.4).
A more detailed description of the sample is presented in Table 1.
3.2. School marks at the age of 16 years, educational level at the age of
34 years and change of cognition
Lower mean of all school marks at the age of 16 years predicted
more decline in VOLT, and abstraction with memory. Lower school
marks in both theoretical and practical school marks predicted decline
in VOLT. Lower practical school marks were associated also withmore
decline in long delay free recall of CVLT, abstractionwithmemory, and
cognitive composite score. Low educational level at the age of
34 years was associated with more decline in abstraction with
memory (Table 2). When associations between the mean of all school
marks and change of VOLT were adjusted additionally (to baseline
Table 1
Baseline characteristics of the sample (n = 41).
Characteristics
Follow-up time, years (mean, SD) 9.1 (0.6)
Females (n, %) 19 (46%)
Education (n, %)
Basic 22 (54%)
Secondary 12 (29%)
Tertiary 7 (17%)
SOFAS (mean, SD) 51.0 (16.5)
Current or earlier alcohol use disorder (n, %) 9 (22.0%)
Age of psychosis onset, years (mean, SD) 23.6 (4.4)
Positive and Negative Syndrome Scale (PANSS) (mean, SD)
Total 52.4 (19.5)
Positive 20.0 (5.7)
Negative 14.8 (9.2)
Cumulative number of hospital treatment days (median, IQR) 161 (44 - 753)
Current use (last 3 months) of antipsychotic medication (n, %)
No current medication 13 (31.7%)
Typical antipsychotic 15 (36.6%)
Atypical antipsychotic 9 (22.0%)
Both typical and atypical antipsychotic 4 (9.8%)
SD = standard deviation, IQR = inter quartile range.
Fig. 1. Association between mean of all school marks and later change of VOLT in
schizophrenia. Interpretation: Poorer school marks associate with more decline in visual
learning and memory in schizophrenia.
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associations remained statistically signiﬁcant. In this model, educational
level at the age of 34 years did not remain statistically signiﬁcant. When
the same adjustments were made for abstraction with memory, none of
the associations remained statistically signiﬁcant. The crude association
between school marks and change of VOLT is illustrated in Fig. 1.
3.3. Severity of illness around ﬁrst episode and change of cognition
Therewerenostatisticallysigniﬁcantassociationsbetweenseverityof illness
or occupational functioning at ﬁrst episode and change of cognition, though
more positive symptoms associated non-signiﬁcantly with less decline,
and more negative symptoms with more decline in cognition (Table 3).
3.4. Later course of illness and change of cognition
Occupational functioning, positive and negative symptoms at later
course of illness did not associate with change of cognition (Table 3).
4. Discussion
4.1. Main ﬁndings
Lower schoolmarks at the age of 16 years and lower education at the
age of 34 years predicted more decline of cognition in schizophrenia inTable 2
School marks and later education as predictors of change of cognition from age 34-years to
The background factors have been analysed separately in different analyses, not in same m
CVLT
Immediate
free recall
CVLT
Long delay
free recall
CVLT
All intrusion
Beta P-value Beta P-value Beta P-
School marks at age 16 years
Mean of all school marks 0.19 0.25 0.20 0.18 −0.09 0.5
Mean of theoretical subjects marks 0.15 0.35 0.15 0.34 −0.04 0.8
Mean of practical subjects marks 0.25 0.13 0.36 0.017 −0.26 0.1
Low education at age 34 –years −0.27 0.51 −0.19 0.60 0.13 0.7
Statistically signiﬁcant results are in bold.
CVLT = California Verbal Learning Test, VOLT = Visual Object Learning Test, AIM = Abstrmidlife. Somewhat surprisingly, and not supporting our hypothesis, the
course of schizophrenia atﬁrst episodeand later courseof schizophrenia
did not predict change of cognition.
4.2. Comparison to earlier studies
To our knowledge, there are no earlier studies on school
performance as a predictor for longitudinal change of cognition in
schizophrenia. Impairment in intellectual ability may exist from early
in life, before the onset of illness, and it is not just a consequence of the
pathological process of disease onset (Aylward et al., 1984; Bora and
Murray, 2014; Fuller et al., 2002). In earlier studies, subjects who
developed schizophrenia were more likely to have had impairments
in childhood educational scores (Jones et al., 1994), and genetic
factors have been proposed to account for poorer school performance
in children of parents with schizophrenia (Jundong et al., 2012). In a
schizophrenia study from Iowa, USA, poor scholastic test scores at
grade 11 (age 16), but not grade 8, predicted poorer IQ, verbal ﬂuency
and auditory verbal learning at ﬁrst episode; there was no association
between scholastic measures and severity of symptoms in this study
(Fuller et al., 2002). These studies and ours support the neurodeve-
lopmental course of development of schizophrenia. In the previous
study of this same NFBC 1966 sample later age of learning to stand at
age about one year associated with more decline in cognition in
schizophrenia, suggesting a putative link between developmental andage 43-years in schizophrenia, adjusted for baseline cognition and age of illness onset.
odel.
s
VOLT AIM, abstraction
without memory
AIM, abstraction
with memory
Composite score
value Beta P-value Beta P-value Beta P-value Beta P-value
9 0.36 0.031 0.05 0.69 0.32 0.038 0.21 0.17
3 0.34 0.043 0.06 0.66 0.28 0.071 0.15 0.33
3 0.38 0.028 0.03 0.81 0.40 0.008 0.38 0.015
0 −0.32 0.42 −0.44 0.15 −0.71 0.038 −0.25 0.38
action, Inhibition and Memory.
Table 3
Severity of illness and functioning as predictors of change of cognition from age 34-years to age 43-years in schizophrenia, adjusted for baseline cognition and age of illness onset.
The background factors have been analysed separately in different analyses, not in same model.
CVLT
Immediate
free recall
CVLT
Long delay
free recall
CVLT
All intrusions
VOLT AIM,
abstraction
without
memory
AIM,
abstraction
with
memory
Composite
score
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Severity of illness around ﬁrst episode
Good occupational functioning 0.26 0.50 0.36 0.39 0.34 0.37 0.07 0.88 0.31 0.35 0.46 0.25 0.11 0.70
Positive symptoms 0.29 0.053 0.26 0.086 0.10 0.53 0.17 0.32 0.02 0.91 0.25 0.10 0.27 0.064
Negative symptoms −0.26 0.088 −0.04 0.81 0.27 0.11 −0.27 0.10 −0.06 0.65 −0.04 0.78 −0.28 0.060
Severity of illness at later course of illness.
at age 34 years
Good occupational functioning
(i.e. not on disability pension)
−0.02 0.97 −0.09 0.86 −0.29 0.46 0.30 0.55 −0.01 0.99 0.31 0.48 0.14 0.70
Positive symptoms 0.05 0.76 0.12 0.49 0.17 0.38 0.05 0.79 −0.04 0.76 0.08 0.67 −0.02 0.93
Negative symptoms −0.10 0.62 0.06 0.76 0.11 0.62 0.16 0.46 −0.16 0.26 0.01 0.96 0.09 0.67
Statistically signiﬁcant results are in bold.
CVLT = California Verbal Learning Test, VOLT = Visual Object Learning Test, AIM = Abstraction, Inhibition and Memory.
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extend our previous work to consider the time of adolescence, as we
demonstrate that poorer school performance at age 16 years is
associated with decline of cognition.
Regarding education and cognition (Ekerholm et al., 2012; Gould
et al., 2012; Han et al., 2012), we have been able to extend earlier
research, and shown that poorer adult educational level has an effect
on longitudinal change of cognition after approximately 20 years of
illness. However, in adjusted analyses only school marks remained
signiﬁcant (educational level non-signiﬁcant). Poorer school achieve-
ments may contribute to poorer adult education that this way may be
associated with change of cognition.
Regarding longitudinal associations between severity of illness
and cognition, in earlier studies cognition has been used as predictor
of later course of illness, where poorer cognition predicted worse
subsequent functional (Allot et al., 2011, Green et al., 2004; Ventura
et al., 2011) and clinical outcomes (Faber et al., 2011). In this same
Northern Finland Birth Cohort 1966 sample poorer cognition at
the age of 34 years predicted poorer vocational and global outcome at
the age of 43 years in schizophrenia (Juola et al., in press). Now we
have shown that symptoms or functioning around the ﬁrst episode or
later course of illness do not greatly predict the change of cognition at
midlife. It may be that after illness onset several other factors may
become more important (compared to severity of symptoms and
functioning) regarding cognition, such as treatments (for example
antipsychotic medication, Husa et al., 2014). However, there was
some statistically non-signiﬁcant association between presence of
positive symptoms and less later decline in cognition, and presence of
negative symptoms and more decline in cognition. Our modest sample
size precludes drawing strong conclusions from negative ﬁndings.
4.3. Theoretical discussion
One potential explanation for association between premorbid
school marks and later change of cognition might be the concept
of cognitive reserve as a protective factor for later life cognitive
impairments. Cognitive reserve, the ability of the mind to compensate
in some way for brain changes, has been proposed in dementia and
ageing research as a moderator between brain change and clinical
outcome (Stern, 2012). In our study lower school marks at age
16-years and lower education at age 34-years predicted more decline
of cognition in midlife schizophrenia. It may be that individuals with
schizophreniawith better premorbid cognition and better educational
attainment can somehow compensate for illness-related deﬁcits,perhaps by employing alternative cognitive and/or neural strategies
to solve cognitive problems in unorthodox ways (Murray et al., 2010).
It is well established that low intelligence is a risk factor for
schizophrenia, and in part this itself may relate to cognitive reserve, as
altered cognitive functions such as attributional biases, or biases in
data gathering, and self-monitoring, may predispose towards the
development of delusions and hallucinations. The neurodevelop-
mental nature of schizophrenia complicates the issue of cognitive
reserve, and the fact that better post-onset cognition predicts better
functioning does not necessarily support the importance of cognitive
reserve, because cognitive impairments in schizophrenia differ
signiﬁcantly at the time of diagnosis (Barnett et al., 2006). However,
one reason to believe that cognitive reserve is an active process in
schizophrenia is that the relationship between intelligence and
schizophrenia is not restricted to the lower end of the intelligence
spectrum: the risk appears to be linear over the IQ range (Jones et al.,
1994), with individuals of average intelligence at signiﬁcantly greater
risk of schizophrenia than individuals with high IQ scores (Zammit et al.,
2004). The protective effects of cognitive reserve would be expected to
operate throughout the range of the intelligence spectrum in thismanner.
Among individuals with schizophrenia higher premorbid and
childhood intelligence has previously been associated with better
social and functional outcome (Aylward et al., 1984; Munro et al.,
2002). Hence, both education and participation in challenging activities
may play a protective role and be potentially useful interventions to
increase resilience in schizophrenia.
The distinctions between premorbid intelligence, post-onset
cognitive ability, and magnitude of participation in the contemporary
information society and in vocational life, may be artiﬁcial. Within the
limits of modest sample size, the current study suggests that there are
cognitive changes in schizophrenia that are systematically associated
with premorbid cognitive functioning and that premorbid cognitive
variables are more sensitive than clinical symptoms as factors for
prediction of the course of cognition. If this suggestion is correct, then
deﬁnition of illness onset becomes more complex. Therefore, further
investigation in this speciﬁc area with larger sample size is needed.
4.4. Strengths and limitations
Compared to previous studies with usually short follow-ups, a long
(nine-year) follow-up interval from ages 34 to 43 years was applied,
which may contribute towards understanding the temporal correla-
tions between predictive factors and change of cognition in early
midlife. The study design made it possible to collect prospective data
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schizophrenia. An earlier study showed that the scholastic test scores
at age 16 years, but not at younger age, predicted cognition after
illness onset (Fuller et al., 2002), so the time frame of the school
performance in our study may be optimal in terms of predicting later
cognition. The general population design of this study decreases the
potential sample selection bias. The birth cohort sample drawn from
the same aged participants helps to minimize variance according to
age variation. We maximised the re-test reliability by using identical
measures of cognition – the CVLT, VOLT and AIM – at both time points.
Limitations of this study should be acknowledged. The lack
on controls limits the ability to make illness speciﬁc conclusions,
and the number of subjects is relatively small. Since cognition was not
measured at early stages of illness, we do not know the timewhen the
observed cognitive decline started. Additionally, we do not know how
the cognitive abilities of the participants affected school achievement
or adult education. We had a limited number of predictors and ﬁrst
episode symptoms were evaluated from hospital notes, not with
questionnaires or interviews.
5. Conclusions
Premorbid school performance, but not so much later course of
schizophrenia, seems to associate with change of cognition in midlife
schizophrenia. These results suggest that the concept of cognitive
reserve as a protective factor for later life cognitive impairment in
the general population may be also relevant at midlife course in
schizophrenia.We speculate that poor premorbid scholastic performance
and post-onset cognitive decline may represent related processes as part
of an endophenotype of schizophrenia.
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